AstraZeneca PLC (NASDAQ:AZN) Given Consensus Rating of "Moderate Buy" by Brokerages
AstraZeneca PLC (NASDAQ:AZN – Get Free Report) has earned an average rating of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among analysts […]